Drug Approval | August 13, 2022
Lupin receives USFDA approval for Meclizine Hydrochloride Tablets USP
The product will be manufactured at Lupin’s facility in Goa, India.
The product will be manufactured at Lupin’s facility in Goa, India.
Margins under pressure - Price erosion, shelf stock adjustments and inventory pare down in US biz impacted margins.
Lupin is the 6th largest company in the Indian Pharmaceutical Market
The product will be manufactured at Lupin's facility in Nagpur, India.
Lupin Diagnostics will equip doctors with accurate diagnosis in the patient journey by leveraging innovative technologies
The US FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Paliperidone Extended-Release Tablets (RLD Invega) had estimated annual sales of USD 152 million in the U.S
Expanding diagnostics footprint in East India
Ivacaftor Tablets had estimated annual sales of USD 109 million in the US.
Lupin recognized the need to digitize more applications, improve scalability, decrease risk of security breaches and eliminate critical data loss
Subscribe To Our Newsletter & Stay Updated
